59M ovarian cancer cells [1.5×106 cells/ml, response normalised to 100% activation] were added to PRP pre-treated with inhibitors and platelet activation was measured by flow cytometry [P-selectin expression]. The gene discussed is SELP; the disease is ovarian carcinoma.